Vancouver, British Columbia – April 3, 2019: AgraFlora Organics International Inc. (CSE: AGRA) (Frankfurt: PU3) (OTC: PUFXF), and Liberty Leaf Holdings Ltd. (CSE: LIB) (OTC: LIBFF) (Frankfurt: HN3P) together, (“the Companies”), are pleased to announce that, further to the joint news release of September 20, 2018, the Companies have made significant advancement with respect to gaining entry into the medical cannabis market in the European Union and, as such, have formed a jointly owned Greek company, AgraLeaf SA (“AgraLeaf”), so as to formally capitalize on the opportunity. AgraFlora and Liberty Leaf will own an equal equity stake in AgraLeaf with specific details regarding the obligations of the Companies to be outlined in a shareholder’s agreement. AgraLeaf has established a team in Greece consisting of personnel with expertise in commercial horticulture, government affairs, legal and finance.
“The new joint venture company will provide access for our shareholders to participate in one of the largest medical cannabis markets in the world,” said Derek Ivany, President and CEO, AgraFlora Organics International Inc. “We have assembled an experienced local management team in Greece and I am confident they possess the skillsets necessary to ensure our success. I look forward to working with Will and the team at Liberty Leaf as we advance this significant opportunity to the mutual benefit of all stakeholders.”
“Having just returned from a due diligence trip, I am extremely impressed with the opportunities for large-scale cannabis cultivation that Greece affords,” said Will Rascan, President and CEO of Liberty Leaf. “AgraFlora has established themselves as capable operators in the burgeoning cannabis marketplace and we are excited about the prospects of working alongside their team as we pursue this exciting new venture in Greece.”
The fertile agricultural regions of Greece combined with relatively low-cost labor and property prices make it a prime locale for large-scale medical cannabis cultivation. In November 2018, Greece issued the first licenses to private companies for growing medicinal cannabis. As a gateway to the European Union, which is home to more than 500 million people, AgraLeaf will thus be granted access to this significant piece of the globalized cannabis market. Recent research reports by Prohibition Partners have estimated that the cannabis market in the EU may represent as much as €123 billion by 2028.
Additional updates and details will be provided in due course as AgraLeaf progresses through the licensing application process.
About AgraFlora Organics International Inc.
Agraflora Organics International is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, Ont., and is a joint venture partner in Propagation Service Canada and its large-scale 2.2-million-square-foot greenhouse complex in Delta, B.C. The company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.
About Liberty Leaf Holdings Ltd.
Liberty Leaf Holdings Ltd. is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD/THC products and supply-chain products within this dynamic and fast-growing sector. For more information please visit: www.libleaf.com.
ON BEHALF OF THE BOARD OF DIRECTORS OF AGRAFLORA ORGANICS INTERNATIONAL INC.,
President & CEO
ON BEHALF OF THE BOARD OF DIRECTORS OF LIBERTY LEAF HOLDINGS LTD.,
President & CEO
For additional information:
AgraFlora Organics International Inc.
T: (800) 783-6056
For French inquiries:
Remy Scalabrini, Maricom Inc.
T: (888) 585-MARI
Liberty Leaf Holdings Ltd.
Toll Free: 1-833-LIB-LEAF (542-5323)
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward‐looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward‐looking statements. The Company disclaims any intention or obligation to revise or update such statements.